vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $236.8M, roughly 1.6× CROSS COUNTRY HEALTHCARE INC). P3 Health Partners Inc. runs the higher net margin — -19.6% vs -35.0%, a 15.4% gap on every dollar of revenue. On growth, P3 Health Partners Inc. posted the faster year-over-year revenue change (3.8% vs -23.6%). Over the past eight quarters, P3 Health Partners Inc.'s revenue compounded faster (-0.5% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
CCRN vs PIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $384.8M |
| Net Profit | $-82.9M | $-75.5M |
| Gross Margin | — | — |
| Operating Margin | -30.2% | -40.0% |
| Net Margin | -35.0% | -19.6% |
| Revenue YoY | -23.6% | 3.8% |
| Net Profit YoY | -2109.7% | -28.8% |
| EPS (diluted) | $-2.56 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $384.8M | ||
| Q3 25 | $250.1M | $345.3M | ||
| Q2 25 | $274.1M | $355.8M | ||
| Q1 25 | $293.4M | $373.2M | ||
| Q4 24 | $309.9M | $370.7M | ||
| Q3 24 | $315.1M | $362.1M | ||
| Q2 24 | $339.8M | $379.2M | ||
| Q1 24 | $379.2M | $388.5M |
| Q4 25 | $-82.9M | $-75.5M | ||
| Q3 25 | $-4.8M | $-31.6M | ||
| Q2 25 | $-6.7M | $-20.4M | ||
| Q1 25 | $-490.0K | $-20.5M | ||
| Q4 24 | $-3.8M | $-58.6M | ||
| Q3 24 | $2.6M | $-46.5M | ||
| Q2 24 | $-16.1M | $-12.0M | ||
| Q1 24 | $2.7M | $-18.7M |
| Q4 25 | — | — | ||
| Q3 25 | 20.4% | — | ||
| Q2 25 | 20.4% | — | ||
| Q1 25 | 20.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 20.4% | — | ||
| Q2 24 | 20.8% | — | ||
| Q1 24 | 20.4% | — |
| Q4 25 | -30.2% | -40.0% | ||
| Q3 25 | -2.4% | -12.8% | ||
| Q2 25 | -2.1% | -9.6% | ||
| Q1 25 | -0.3% | -10.2% | ||
| Q4 24 | -1.1% | -37.4% | ||
| Q3 24 | 0.9% | -29.5% | ||
| Q2 24 | -5.7% | -8.3% | ||
| Q1 24 | 0.8% | -11.3% |
| Q4 25 | -35.0% | -19.6% | ||
| Q3 25 | -1.9% | -9.1% | ||
| Q2 25 | -2.4% | -5.7% | ||
| Q1 25 | -0.2% | -5.5% | ||
| Q4 24 | -1.2% | -15.8% | ||
| Q3 24 | 0.8% | -12.8% | ||
| Q2 24 | -4.7% | -3.2% | ||
| Q1 24 | 0.7% | -4.8% |
| Q4 25 | $-2.56 | $-23.08 | ||
| Q3 25 | $-0.15 | $-9.67 | ||
| Q2 25 | $-0.20 | $-6.23 | ||
| Q1 25 | $-0.02 | $-6.28 | ||
| Q4 24 | $-0.13 | $-23.13 | ||
| Q3 24 | $0.08 | $-15.70 | ||
| Q2 24 | $-0.47 | $-7.37 | ||
| Q1 24 | $0.08 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $25.0M |
| Total DebtLower is stronger | — | $228.4M |
| Stockholders' EquityBook value | $322.8M | $-155.2M |
| Total Assets | $449.0M | $656.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $25.0M | ||
| Q3 25 | $99.1M | $37.7M | ||
| Q2 25 | $81.2M | $38.6M | ||
| Q1 25 | $80.7M | $40.1M | ||
| Q4 24 | $81.6M | $38.8M | ||
| Q3 24 | $64.0M | $63.0M | ||
| Q2 24 | $69.6M | $73.1M | ||
| Q1 24 | $5.2M | $27.3M |
| Q4 25 | — | $228.4M | ||
| Q3 25 | — | $252.8M | ||
| Q2 25 | — | $182.0M | ||
| Q1 25 | — | $171.1M | ||
| Q4 24 | — | $108.9M | ||
| Q3 24 | — | $133.2M | ||
| Q2 24 | — | $133.1M | ||
| Q1 24 | — | $118.1M |
| Q4 25 | $322.8M | $-155.2M | ||
| Q3 25 | $408.1M | $-18.7M | ||
| Q2 25 | $412.2M | $44.5M | ||
| Q1 25 | $418.2M | $63.3M | ||
| Q4 24 | $419.0M | $75.9M | ||
| Q3 24 | $424.7M | $120.5M | ||
| Q2 24 | $433.3M | $166.8M | ||
| Q1 24 | $462.4M | $146.6M |
| Q4 25 | $449.0M | $656.6M | ||
| Q3 25 | $538.2M | $683.6M | ||
| Q2 25 | $553.8M | $731.6M | ||
| Q1 25 | $576.2M | $783.9M | ||
| Q4 24 | $589.3M | $783.4M | ||
| Q3 24 | $597.4M | $833.3M | ||
| Q2 24 | $602.9M | $892.8M | ||
| Q1 24 | $648.4M | $855.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.09× | ||
| Q1 25 | — | 2.71× | ||
| Q4 24 | — | 1.43× | ||
| Q3 24 | — | 1.11× | ||
| Q2 24 | — | 0.80× | ||
| Q1 24 | — | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $-25.7M |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $-25.7M | ||
| Q3 25 | $20.1M | $-15.4M | ||
| Q2 25 | $4.2M | $-16.6M | ||
| Q1 25 | $5.7M | $-33.5M | ||
| Q4 24 | $24.2M | $-57.2M | ||
| Q3 24 | $7.5M | $-22.6M | ||
| Q2 24 | $82.4M | $-10.2M | ||
| Q1 24 | $6.0M | $-20.0M |
| Q4 25 | $16.1M | — | ||
| Q3 25 | $17.9M | — | ||
| Q2 25 | $2.3M | — | ||
| Q1 25 | $3.8M | — | ||
| Q4 24 | $21.7M | — | ||
| Q3 24 | $6.3M | — | ||
| Q2 24 | $79.6M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 23.4% | — | ||
| Q1 24 | 1.0% | — |
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.8% | 0.0% | ||
| Q3 24 | 0.4% | 0.0% | ||
| Q2 24 | 0.8% | 0.0% | ||
| Q1 24 | 0.6% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
